584 related articles for article (PubMed ID: 29428899)
1. Efficacy of lacosamide in children and adolescents with drug-resistant epilepsy and refractory status epilepticus: A systematic review.
Ortiz de la Rosa JS; Ladino LD; Rodríguez PJ; Rueda MC; Polanía JP; Castañeda AC
Seizure; 2018 Mar; 56():34-40. PubMed ID: 29428899
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Tolerability of Lacosamide in the Treatment of Children With Refractory Generalized Epilepsy.
Miskin C; Khurana DS; Valencia I; Legido A; Hasbani DM; Carvalho KS
J Child Neurol; 2016 Jun; 31(7):925-8. PubMed ID: 26887412
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of lacosamide as an adjunctive therapy for refractory focal epilepsy in paediatric patients: a retrospective single-centre study.
Toupin JF; Lortie A; Major P; Diadori P; Vanasse M; Rossignol E; D'Anjou G; Perreault S; Larbrisseau A; Carmant L; Birca A
Epileptic Disord; 2015 Dec; 17(4):436-43. PubMed ID: 26609635
[TBL] [Abstract][Full Text] [Related]
4. Lacosamide treatment of childhood refractory focal epilepsy: the first reported side effect in paediatric patients.
Yildiz EP; Ozkan MU; Bektas G; Uzunhan TA; Aydinli N; Caliskan M; Ozmen M
Childs Nerv Syst; 2017 Nov; 33(11):2023-2027. PubMed ID: 28884208
[TBL] [Abstract][Full Text] [Related]
5. Lacosamide as adjunctive therapy in refractory epilepsy in adults: a systematic review.
Paquette V; Culley C; Greanya ED; Ensom MH
Seizure; 2015 Feb; 25():1-17. PubMed ID: 25645629
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of lacosamide as adjunctive therapy in children with refractory epilepsy.
Yorns WR; Khurana DS; Carvalho KS; Hardison HH; Legido A; Valencia I
J Child Neurol; 2014 Jan; 29(1):23-7. PubMed ID: 23143718
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Tolerability of Lacosamide in Lennox-Gastaut Syndrome: A Systematic Review and Meta-analysis.
Panda PK; Sharawat IK; Dawman L; Panda P; Kasinathan A; Rathaur VK
J Neurosci Rural Pract; 2022 Jan; 13(1):32-42. PubMed ID: 35110918
[No Abstract] [Full Text] [Related]
8. Intravenous Lacosamide in Pediatric Status Epilepticus: An Open-Label Efficacy and Safety Study.
Poddar K; Sharma R; Ng YT
Pediatr Neurol; 2016 Aug; 61():83-6. PubMed ID: 27241232
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness and safety of lacosamide in children with epilepsy in a clinical practice setting.
Sanmartí-Vilaplana F; Díaz-Gómez A
Epilepsy Behav; 2018 Feb; 79():130-137. PubMed ID: 29287216
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain.
Casas-Fernández C; Martínez-Bermejo A; Rufo-Campos M; Smeyers-Durá P; Herranz-Fernández JL; Ibáñez-Micó S; Campistol-Plana J; Alarcón-Martínez H; Campos-Castelló J
Drugs R D; 2012 Dec; 12(4):187-97. PubMed ID: 23193979
[TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy of add-on lacosamide treatment in children and adolescents with refractory epilepsies: A single-center observational study.
Rosati A; Ilvento L; Rizzi R; Doccini V; Leo MC; Pugi A; De Masi S; Guerrini R
Epilepsia; 2018 May; 59(5):1004-1010. PubMed ID: 29663335
[TBL] [Abstract][Full Text] [Related]
12. Lacosamide in refractory mixed pediatric epilepsy: a prospective add-on study.
Rastogi RG; Ng YT
J Child Neurol; 2012 Apr; 27(4):492-5. PubMed ID: 22467791
[TBL] [Abstract][Full Text] [Related]
13. Lacosamide in status epilepticus: Systematic review of current evidence.
Strzelczyk A; Zöllner JP; Willems LM; Jost J; Paule E; Schubert-Bast S; Rosenow F; Bauer S
Epilepsia; 2017 Jun; 58(6):933-950. PubMed ID: 28295226
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
[TBL] [Abstract][Full Text] [Related]
15. Lacosamide as an adjunctive therapy in pediatric patients with refractory focal epilepsy.
Kim JS; Kim H; Lim BC; Chae JH; Choi J; Kim KJ; Hwang YS; Hwang H
Brain Dev; 2014 Jun; 36(6):510-5. PubMed ID: 23948372
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of add-on lacosamide in children with Lennox-Gastaut syndrome.
Grosso S; Coppola G; Cusmai R; Parisi P; Spalice A; Foligno S; Verrotti A; Balestri P
Acta Neurol Scand; 2014 Jun; 129(6):420-4. PubMed ID: 24479878
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US.
Sands TT; Rahdari S; Oldham MS; Caminha Nunes E; Tilton N; Cilio MR
CNS Drugs; 2019 Jan; 33(1):47-60. PubMed ID: 30460546
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of add-on Lacosamide treatment in adults with Lennox-Gastaut syndrome: An observational study.
Andrade-Machado R; Luque-Navarro-de Los Reyes J; Benjumea-Cuartas V; Restrepo JF; Jaramillo-Jiménez E; Andrade-Gutierrez G; Espinosa AG
Seizure; 2015 Dec; 33():81-7. PubMed ID: 26606192
[TBL] [Abstract][Full Text] [Related]
19. Lacosamide and epilepsy.
Harris JA; Murphy JA
CNS Neurosci Ther; 2011 Dec; 17(6):678-82. PubMed ID: 20950330
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of childhood prolonged refractory status epilepticus with lacosamide.
Shiloh-Malawsky Y; Fan Z; Greenwood R; Tennison M
Seizure; 2011 Sep; 20(7):586-8. PubMed ID: 21474342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]